PeerView Oncology

 

Hematologic Oncology
08:47

PeerView Oncology

Personalized Care in CLL: Targeting BCL-2 & Review of Studies with Venetoclax (Venetoclax + Rituximab in R/R Disease & Obinutuzumab + Venetoclax in First-Line Setting)

FEATURING Ryan Jacobs
  • 179 views
  • March 26, 2020
16:56

PeerView Oncology

Personalized Care in CLL: Treatment Pathway for Younger vs Older Pts, Summary of Major Studies With BTKi Ibrutinib and Acalabrutinib

FEATURING Ryan Jacobs
  • 245 views
  • March 26, 2020
  • 2
18:43

PeerView Oncology

Management of R/R MCL: Ibrutinib and Acalabrutinib Data, Venetoclax Monotherapy, Combination Therapies & BTK Inhibitor AE Management

FEATURING Jia Ruan
  • 464 views
  • March 25, 2020
  • 3
08:56

PeerView Oncology

Management of R/R MCL: Lenalidomide w/ Rituximab & CAR T Therapy

FEATURING Jia Ruan
  • 633 views
  • March 25, 2020
  • 4